2022
DOI: 10.1007/s00415-022-11434-y
|View full text |Cite|
|
Sign up to set email alerts
|

Can novel CT-and MR-based neuroimaging biomarkers further improve the etiological diagnosis of lobar intra-cerebral hemorrhage?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…However, survivors of cerebral hemorrhage are often accompanied by many neurological sequelae that impair quality of life. In clinical treatment, it is necessary to distinguish ICH subtypes in patients with ICH, as the risk of recurrence of cerebral amyloid angiopathy (CAA)-related ICH is approximately 7% per year [ 5 ], and the risk of recurrence of non-CAA-related ICH is significantly lower. Moreover, the differentiation of cerebral hemorrhage subtypes is also meaningful for later clinical decision-making.…”
Section: Introductionmentioning
confidence: 99%
“…However, survivors of cerebral hemorrhage are often accompanied by many neurological sequelae that impair quality of life. In clinical treatment, it is necessary to distinguish ICH subtypes in patients with ICH, as the risk of recurrence of cerebral amyloid angiopathy (CAA)-related ICH is approximately 7% per year [ 5 ], and the risk of recurrence of non-CAA-related ICH is significantly lower. Moreover, the differentiation of cerebral hemorrhage subtypes is also meaningful for later clinical decision-making.…”
Section: Introductionmentioning
confidence: 99%